Type 1 interferonopathy
MONDO:0700264Conditions in which increased type 1 interferon signaling leads to autoimmune and neurological disorders. These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response.
31 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Aicardi-Goutieres syndrome
(9)
Autoimmune interstitial lung disease-arthritis syndrome
(3)
Deficiency of adenosine deaminase 2
(3)
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
(3)
Aicardi-Goutieres syndrome 1
(2)
Familial chilblain lupus
(2)
Proteosome-associated autoinflammatory syndrome
(2)
STING-associated vasculopathy with onset in infancy
(2)
Dyschromatosis symmetrica hereditaria
(1)
Proteasome-associated autoinflammatory syndrome 1
(1)
Singleton-Merten dysplasia
(1)
ADAR-related type 1 interferonopathy
(0)
Aicardi-Goutieres syndrome 2
(0)
Aicardi-Goutieres syndrome 3
(0)
Aicardi-Goutieres syndrome 4
(0)
Aicardi-Goutieres syndrome 5
(0)
Aicardi-Goutieres syndrome 6
(0)
Aicardi-Goutieres syndrome 7
(0)
Aicardi-Goutieres syndrome 8
(0)
Aicardi-Goutieres syndrome 9
(0)